FDA clearance is a critical regulatory milestone that can significantly impact a healthcare company's ability to market and sell its products. For Nanox, this approval for HealthFLD not only validates the technology but also opens up the lucrative U.S. healthcare market for its commercialization efforts. This development is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term as it represents both a validation of Nanox's technology and a significant market opportunity.